-
1
-
-
58149152733
-
"APRIL hath put a spring of youth in everything": Relevance of APRIL for survival
-
Kimberley FC, Hahne M, Medema JP. "APRIL hath put a spring of youth in everything": Relevance of APRIL for survival. J Cell Physiol. 2009;218(1):1-8.
-
(2009)
J Cell Physiol
, vol.218
, Issue.1
, pp. 1-8
-
-
Kimberley, F.C.1
Hahne, M.2
Medema, J.P.3
-
2
-
-
0141927968
-
The uncertain glory of APRIL
-
DOI 10.1038/sj.cdd.4401291
-
Medema JP, Planelles-Carazo L, Hardenberg G, Hahne M. The uncertain glory of APRIL. Cell Death Differ. 2003;10(10):1121-1125. (Pubitemid 37258577)
-
(2003)
Cell Death and Differentiation
, vol.10
, Issue.10
, pp. 1121-1125
-
-
Medema, J.P.1
Planelles-Carazo, L.2
Hardenberg, G.3
Hahne, M.4
-
3
-
-
0034729769
-
Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
-
DOI 10.1016/S0960-9822(00)00566-2
-
Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol. 2000;10(13):785-788. (Pubitemid 30466942)
-
(2000)
Current Biology
, vol.10
, Issue.13
, pp. 785-788
-
-
Marsters, S.A.1
Yan, M.2
Pitti, R.M.3
Haas, P.E.4
Dixit, V.M.5
Ashkenazi, A.6
-
4
-
-
0034606225
-
A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth
-
Rennert P, Schneider P, Cachero TG, et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med. 2000;192(11):1677-1684.
-
(2000)
J Exp Med
, vol.192
, Issue.11
, pp. 1677-1684
-
-
Rennert, P.1
Schneider, P.2
Cachero, T.G.3
-
5
-
-
0034634625
-
Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS
-
Wu Y, Bressette D, Carrell JA, et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J Biol Chem. 2000;275(45):35478-35485.
-
(2000)
J Biol Chem
, vol.275
, Issue.45
, pp. 35478-35485
-
-
Wu, Y.1
Bressette, D.2
Carrell, J.A.3
-
6
-
-
5944227779
-
APRIL and TALL-I and receptors BCMA and TACI: System for regulating humoral immunity
-
Yu G, Boone T, Delaney J, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol. 2000;1(3):252-256.
-
(2000)
Nat Immunol
, vol.1
, Issue.3
, pp. 252-256
-
-
Yu, G.1
Boone, T.2
Delaney, J.3
-
7
-
-
0035860466
-
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF
-
DOI 10.1126/science.1061965
-
Thompson JS, Bixler SA, Qian F, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001;293(5537):2108- 2111. (Pubitemid 32848062)
-
(2001)
Science
, vol.293
, Issue.5537
, pp. 2108-2111
-
-
Thompson, J.S.1
Bixler, S.A.2
Qian, F.3
Vora, K.4
Scott, M.L.5
Cachero, T.G.6
Hession, C.7
Schneider, P.8
Sizing, I.D.9
Mullen, C.10
Strauch, K.11
Zafari, M.12
Benjamin, C.D.13
Tschopp, J.14
Browning, J.L.15
Ambrose, C.16
-
8
-
-
20044369789
-
Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation
-
DOI 10.1038/sj.cdd.4401647
-
Hendriks J, Planelles L, Jong-Odding J, et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 2005;12(6):637-648. (Pubitemid 40767166)
-
(2005)
Cell Death and Differentiation
, vol.12
, Issue.6
, pp. 637-648
-
-
Hendriks, J.1
Planelles, L.2
De Jong-Odding, J.3
Hardenberg, G.4
Pals, S.T.5
Hahne, M.6
Spaargaren, M.7
Medema, J.P.8
-
9
-
-
20844432040
-
Identification of proteoglycans as the APRIL-specific binding partners
-
DOI 10.1084/jem.20042309
-
Ingold K, Zumsteg A, Tardivel A, et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med. 2005;201(9):1375-1383. (Pubitemid 40664082)
-
(2005)
Journal of Experimental Medicine
, vol.201
, Issue.9
, pp. 1375-1383
-
-
Ingold, K.1
Zumsteg, A.2
Tardivel, A.3
Huard, B.4
Steiner, Q.-G.5
Cachero, T.G.6
Qiang, F.7
Gorelik, L.8
Kalled, S.L.9
Acha-Orbea, H.10
Rennert, P.D.11
Tschopp, J.12
Schneider, P.13
-
10
-
-
48749100460
-
APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa
-
Huard B, McKee T, Bosshard C, et al. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest. 2008;118(8):2887-2895.
-
(2008)
J Clin Invest
, vol.118
, Issue.8
, pp. 2887-2895
-
-
Huard, B.1
McKee, T.2
Bosshard, C.3
-
11
-
-
70349314412
-
The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking
-
Kimberley FC, van Bostelen L, Cameron K, et al. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J. 2009;23(5):1584-1595.
-
(2009)
FASEB J
, vol.23
, Issue.5
, pp. 1584-1595
-
-
Kimberley, F.C.1
Van Bostelen, L.2
Cameron, K.3
-
12
-
-
33947592601
-
TACI regulates IgA production by APRIL in collaboration with HSPG
-
DOI 10.1182/blood-2006-08-041772
-
Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood. 2007;109(7):2961- 2967. (Pubitemid 46482094)
-
(2007)
Blood
, vol.109
, Issue.7
, pp. 2961-2967
-
-
Sakurai, D.1
Hase, H.2
Kanno, Y.3
Kojima, H.4
Okumura, K.5
Kobata, T.6
-
13
-
-
0032555931
-
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth
-
DOI 10.1084/jem.188.6.1185
-
Hahne M, Kataoka T, Schroter M, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med. 1998;188(6):1185-1190. (Pubitemid 28443341)
-
(1998)
Journal of Experimental Medicine
, vol.188
, Issue.6
, pp. 1185-1190
-
-
Hahne, M.1
Kataoka, T.2
Schroter, M.3
Hofmann, K.4
Irmler, M.5
Bodmer, J.-L.6
Schneider, P.7
Bornand, T.8
Holler, N.9
French, L.E.10
Sordat, B.11
Rimoldi, D.12
Tschopp, J.13
-
14
-
-
33644755600
-
An APRIL to remember: Novel TNF ligands as therapeutic targets
-
DOI 10.1038/nrd1982, PII N1982
-
Dillon SR, Gross JA, Ansell SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov. 2006;5(3):235-246. (Pubitemid 43336036)
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, Issue.3
, pp. 235-246
-
-
Dillon, S.R.1
Gross, J.A.2
Ansell, S.M.3
Novak, A.J.4
-
16
-
-
0036081039
-
APRIL modulates B and T cell immunity
-
DOI 10.1172/JCI200215034
-
Stein JV, Lopez-Fraga M, Elustondo FA, et al. APRIL modulates B and T cell immunity. J Clin Invest. 2002;109(12):1587-1598. (Pubitemid 34663521)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.12
, pp. 1587-1598
-
-
Stein, J.V.1
Lopez-Fraga, M.2
Elustondo, F.A.3
Carvalho-Pinto, C.E.4
Rodriguez, D.5
Gomez-Caro, R.6
De Jong, J.7
Martinez-A, C.8
Medema, J.P.9
Hahne, M.10
-
17
-
-
9144244788
-
APRIL-Deficient Mice Have Normal Immune System Development
-
DOI 10.1128/MCB.24.3.997-1006.2004
-
Varfolomeev E, Kischkel F, Martin F, et al. APRIL-deficient mice have normal immune system development. Mol Cell Biol. 2004;24(3):997-1006. (Pubitemid 38112165)
-
(2004)
Molecular and Cellular Biology
, vol.24
, Issue.3
, pp. 997-1006
-
-
Varfolomeev, E.1
Kischkel, F.2
Martin, F.3
Seshasayee, D.4
Wang, H.5
Lawrence, D.6
Olsson, C.7
Tom, L.8
Erickson, S.9
French, D.10
Schow, P.11
Grewal, I.S.12
Ashkenazi, A.13
-
18
-
-
41949138741
-
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
-
Belnoue E, Pihlgren M, McGaha TL, et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood. 2008;111(5):2755-2764.
-
(2008)
Blood
, vol.111
, Issue.5
, pp. 2755-2764
-
-
Belnoue, E.1
Pihlgren, M.2
McGaha, T.L.3
-
19
-
-
1642332951
-
Impaired IgA class switching inn APRIL-deficient mice
-
DOI 10.1073/pnas.0307348101
-
Castigli E, Scott S, Dedeoglu F, et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A. 2004;101(11):3903-3908. (Pubitemid 38381075)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.11
, pp. 3903-3908
-
-
Castigli, E.1
Scott, S.2
Dedeoglu, F.3
Bryce, P.4
Jabara, H.5
Bhan, A.K.6
Mizoguchi, E.7
Geha, R.S.8
-
20
-
-
34250205694
-
2 Class Switching by Inducing Epithelial-Cell Secretion of the Cytokine APRIL
-
DOI 10.1016/j.immuni.2007.04.014, PII S1074761307002877
-
He B, Xu W, Santini PA, et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity. 2007;26(6):812-826. (Pubitemid 46915505)
-
(2007)
Immunity
, vol.26
, Issue.6
, pp. 812-826
-
-
He, B.1
Xu, W.2
Santini, P.A.3
Polydorides, A.D.4
Chiu, A.5
Estrella, J.6
Shan, M.7
Chadburn, A.8
Villanacci, V.9
Plebani, A.10
Knowles, D.M.11
Rescigno, M.12
Cerutti, A.13
-
21
-
-
49649112162
-
Thymus-independent class switch recombination is affected by APRIL
-
Hardenberg G, van Bostelen L, Hahne M, Medema JP. Thymus-independent class switch recombination is affected by APRIL. Immunol Cell Biol. 2008;86(6):530-534.
-
(2008)
Immunol Cell Biol
, vol.86
, Issue.6
, pp. 530-534
-
-
Hardenberg, G.1
Van Bostelen, L.2
Hahne, M.3
Medema, J.P.4
-
22
-
-
33846258010
-
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway
-
DOI 10.1182/blood-2006-06-027755
-
Endo T, Nishio M, Enzler T, et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood. 2007;109(2):703-710. (Pubitemid 46105972)
-
(2007)
Blood
, vol.109
, Issue.2
, pp. 703-710
-
-
Endo, T.1
Nishio, M.2
Enzler, T.3
Cottam, H.B.4
Fukuda, T.5
James, D.F.6
Karin, M.7
Kipps, T.J.8
-
23
-
-
67149099805
-
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation
-
Gupta M, Dillon SR, Ziesmer SC, et al. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. Blood. 2009;113(21):5206-5216.
-
(2009)
Blood
, vol.113
, Issue.21
, pp. 5206-5216
-
-
Gupta, M.1
Dillon, S.R.2
Ziesmer, S.C.3
-
24
-
-
11144355586
-
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
-
DOI 10.1182/blood-2003-06-1984
-
Moreaux J, Legouffe E, Jourdan E, et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood. 2004;103(8):3148-3157. (Pubitemid 38451693)
-
(2004)
Blood
, vol.103
, Issue.8
, pp. 3148-3157
-
-
Moreaux, J.1
Legouffe, E.2
Jourdan, E.3
Quittet, P.4
Reme, T.5
Lugagne, C.6
Moine, P.7
Rossi, J.-F.8
Klein, B.9
Tarte, K.10
-
25
-
-
5444241123
-
APRIL promotes B-1 cell-associated neoplasm
-
DOI 10.1016/j.ccr.2004.08.033, PII S1535610804002739
-
Planelles L, Carvalho-Pinto CE, Hardenberg G, et al. APRIL promotes B-1 cell-associated neoplasm. Cancer Cell. 2004;6(4):399-408. (Pubitemid 39361440)
-
(2004)
Cancer Cell
, vol.6
, Issue.4
, pp. 399-408
-
-
Planelles, L.1
Carvalho-Pinto, C.E.2
Hardenberg, G.3
Smaniotto, S.4
Savino, W.5
Gomez-Caro, R.6
Alvarez-Mon, M.7
De Jong, J.8
Eldering, E.9
Martinez-A, C.10
Medema, J.P.11
Hahne, M.12
-
26
-
-
33845969135
-
Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness
-
DOI 10.1182/blood-2006-02-001800
-
Schwaller J, Schneider P, Mhawech-Fauceglia P, et al. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood. 2007;109(1):331-338. (Pubitemid 46053074)
-
(2007)
Blood
, vol.109
, Issue.1
, pp. 331-338
-
-
Schwaller, J.1
Schneider, P.2
Mhawech-Fauceglia, P.3
McKee, T.4
Myit, S.5
Matthes, T.6
Tschopp, J.7
Donze, O.8
Le, G.F.-A.9
Huard, B.10
-
28
-
-
55049131371
-
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia
-
Molica S, Digiesi G, Mauro F, et al. Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia. Leuk Res. 2009;33(1):162-165.
-
(2009)
Leuk Res
, vol.33
, Issue.1
, pp. 162-165
-
-
Molica, S.1
Digiesi, G.2
Mauro, F.3
-
29
-
-
36348943503
-
APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: Prognostic relevance of APRIL for survival
-
DOI 10.3324/haematol.10317
-
Planelles L, Castillo-Gutierrez S, Medema JP, Morales-Luque A, Merle-Beral H, Hahne M. APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica. 2007;92(9):1284-1285. (Pubitemid 350144199)
-
(2007)
Haematologica
, vol.92
, Issue.9
, pp. 1284-1285
-
-
Planelles, L.1
Castillo-Gutierrez, S.2
Medema, J.P.3
Morales-Luque, A.4
Merle-Beral, H.5
Hahne, M.6
-
30
-
-
67650721105
-
APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop
-
Moreaux J, Sprynski AC, Dillon SR, et al. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop. Eur J Haematol. 2009;83(2):119-129.
-
(2009)
Eur J Haematol
, vol.83
, Issue.2
, pp. 119-129
-
-
Moreaux, J.1
Sprynski, A.C.2
Dillon, S.R.3
-
31
-
-
54949118810
-
Atacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells
-
Gatto B. Atacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells. Curr Opin Investig Drugs. 2008;9(11):1216-1227.
-
(2008)
Curr Opin Investig Drugs
, vol.9
, Issue.11
, pp. 1216-1227
-
-
Gatto, B.1
-
32
-
-
78649955057
-
Belimumab: A BLyS-specific inhibitor for systemic lupus erythematosus
-
Wiglesworth AK, Ennis KM, Kockler DR. Belimumab: a BLyS-specific inhibitor for systemic lupus erythematosus. Ann Pharmacother. 2010;44(12):1955-1961.
-
(2010)
Ann Pharmacother
, vol.44
, Issue.12
, pp. 1955-1961
-
-
Wiglesworth, A.K.1
Ennis, K.M.2
Kockler, D.R.3
-
33
-
-
17944375043
-
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS
-
DOI 10.1016/S1074-7613(01)00183-2
-
Gross JA, Dillon SR, Mudri S, et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity. 2001;15(2):289-302. (Pubitemid 32816877)
-
(2001)
Immunity
, vol.15
, Issue.2
, pp. 289-302
-
-
Gross, J.A.1
Dillon, S.R.2
Mudri, S.3
Johnston, J.4
Littau, A.5
Roque, R.6
Rixon, M.7
Schou, O.8
Foley, K.P.9
Haugen, H.10
McMillen, S.11
Waggie, K.12
Schreckhise, R.W.13
Shoemaker, K.14
Vu, T.15
Moore, M.16
Grossman, A.17
Clegg, C.H.18
-
35
-
-
13544261427
-
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA
-
DOI 10.1021/bi048227k
-
Day ES, Cachero TG, Qian F, et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry. 2005;44(6):1919-1931. (Pubitemid 40223621)
-
(2005)
Biochemistry
, vol.44
, Issue.6
, pp. 1919-1931
-
-
Day, E.S.1
Cachero, T.G.2
Qian, F.3
Sun, Y.4
Wen, D.5
Pelletier, M.6
Hsu, Y.-M.7
Whitty, A.8
-
36
-
-
0035803468
-
Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen
-
DOI 10.1084/jem.194.11.1691
-
Schneider P, Takatsuka H, Wilson A, et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med. 2001;194(11):1691-1697. (Pubitemid 33126819)
-
(2001)
Journal of Experimental Medicine
, vol.194
, Issue.11
, pp. 1691-1697
-
-
Schneider, P.1
Takatsuka, H.2
Wilson, A.3
Mackay, F.4
Tardivel, A.5
Lens, S.6
Cachero, T.G.7
Finke, D.8
Beermann, F.9
Tschopp, J.10
-
37
-
-
23044514711
-
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha
-
DOI 10.1182/blood-2004-03-0889
-
Nishio M, Endo T, Tsukada N, et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood. 2005;106(3):1012- 1020. (Pubitemid 41076448)
-
(2005)
Blood
, vol.106
, Issue.3
, pp. 1012-1020
-
-
Nishio, M.1
Endo, T.2
Tsukada, N.3
Ohata, J.4
Kitada, S.5
Reed, J.C.6
Zvaifler, N.J.7
Kipps, T.J.8
-
38
-
-
34547772125
-
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
-
DOI 10.1084/jem.20062567
-
Groom JR, Fletcher CA, Walters SN, et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med. 2007;204(8):1959-1971. (Pubitemid 47236330)
-
(2007)
Journal of Experimental Medicine
, vol.204
, Issue.8
, pp. 1959-1971
-
-
Groom, J.R.1
Fletcher, C.A.2
Walters, S.N.3
Grey, S.T.4
Watt, S.V.5
Sweet, M.J.6
Smyth, M.J.7
Mackay, C.R.8
Mackay, F.9
-
39
-
-
8644243182
-
Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis
-
DOI 10.1182/blood-2003-11-3861
-
Bonci D, Hahne M, Felli N, Peschle C, De Maria R. Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis. Blood. 2004;104(10):3169-3172. (Pubitemid 39507131)
-
(2004)
Blood
, vol.104
, Issue.10
, pp. 3169-3172
-
-
Bonci, D.1
Hahne, M.2
Felli, N.3
Peschle, C.4
De Maria, R.5
-
40
-
-
77956916950
-
Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow
-
Winter O, Moser K, Mohr E, et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood. 2010;116(11):1867- 1875.
-
(2010)
Blood
, vol.116
, Issue.11
, pp. 1867-1875
-
-
Winter, O.1
Moser, K.2
Mohr, E.3
-
41
-
-
39149085356
-
high primary myeloma cells in SCID-hu mice and in coculture with osteoclasts
-
DOI 10.1038/sj.leu.2405048, PII 2405048
-
Yaccoby S, Pennisi A, Li X, et al. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts. Leukemia. 2008;22(2):406-413. (Pubitemid 351250547)
-
(2008)
Leukemia
, vol.22
, Issue.2
, pp. 406-413
-
-
Yaccoby, S.1
Pennisi, A.2
Li, X.3
Dillon, S.R.4
Zhan, F.5
Barlogie, B.6
Shaughnessy Jr., J.D.7
-
42
-
-
70350734809
-
The microenvironment in mature B-cell malignancies: A target for new treatment strategies
-
Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood. 2009;114(16):3367-3375.
-
(2009)
Blood
, vol.114
, Issue.16
, pp. 3367-3375
-
-
Burger, J.A.1
Ghia, P.2
Rosenwald, A.3
Caligaris-Cappio, F.4
-
43
-
-
49349099119
-
Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy
-
Kim SJ, Lee SJ, Choi IY, et al. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy. Eur J Haematol. 2008;81(3):177-184.
-
(2008)
Eur J Haematol
, vol.81
, Issue.3
, pp. 177-184
-
-
Kim, S.J.1
Lee, S.J.2
Choi, I.Y.3
-
44
-
-
4043146475
-
B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation
-
Shulga-Morskaya S, Dobles M, Walsh ME, et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol. 2004;173(4):2331-2341. (Pubitemid 39063089)
-
(2004)
Journal of Immunology
, vol.173
, Issue.4
, pp. 2331-2341
-
-
Shulga-Morskaya, S.1
Dobles, M.2
Walsh, M.E.3
Ng, L.G.4
MacKay, F.5
Rao, S.P.6
Kalled, S.L.7
Scott, M.L.8
-
45
-
-
37149032474
-
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial
-
DOI 10.1002/art.23047
-
Dall'Era M, Chakravarty E, Wallace D, et al. Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Arthritis Rheum. 2007;56(12):4142- 4150. (Pubitemid 350262342)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.12
, pp. 4142-4150
-
-
Dall'Era, M.1
Chakravarty, E.2
Wallace, D.3
Genovese, M.4
Weisman, M.5
Kavanaugh, A.6
Kalunian, K.7
Dhar, P.8
Vincent, E.9
Pena-Rossi, C.10
Wofsy, D.11
Alum, N.12
Dubois, A.13
Kinnman, N.14
Picard, M.15
Bortolotti, A.16
O'Grady, L.17
Hill, J.18
Nestorov, I.19
Salmon, E.20
more..
-
46
-
-
73949102012
-
Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus
-
Nestorov I, Papasouliotis O, Pena RC, Munafo A. Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus. J Pharm Sci. 2010;99(1):524-538.
-
(2010)
J Pharm Sci
, vol.99
, Issue.1
, pp. 524-538
-
-
Nestorov, I.1
Papasouliotis, O.2
Pena, R.C.3
Munafo, A.4
-
47
-
-
65149106325
-
An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
-
Pena-Rossi C, Nasonov E, Stanislav M, et al. An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus. Lupus. 2009;18(6):547-555.
-
(2009)
Lupus
, vol.18
, Issue.6
, pp. 547-555
-
-
Pena-Rossi, C.1
Nasonov, E.2
Stanislav, M.3
-
48
-
-
54349100000
-
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: A phase I trial in patients with systemic lupus erythematosus
-
Furie R, Stohl W, Ginzler EM, et al. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther. 2008;10(5):R109.
-
(2008)
Arthritis Res Ther
, vol.10
, Issue.5
-
-
Furie, R.1
Stohl, W.2
Ginzler, E.M.3
-
49
-
-
63849239722
-
APRIL is overexpressed in cancer: Link with tumor progression
-
Moreaux J, Veyrune JL, De Vos J, Klein B. APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer. 2009;9:83.
-
(2009)
BMC Cancer
, vol.9
, pp. 83
-
-
Moreaux, J.1
Veyrune, J.L.2
De Vos, J.3
Klein, B.4
|